It's time to phase out the "patch and pray" approach, eliminate needless public interfaces, and enforce authentication ...
Q4 2025 EPS At the High End of Guidance Range, Both Revenue and GM In-Line With Guidance Issued on November 6, 2025Company Q1 2026 Guidance: Revenues to Decline 2.0% to 6.0% QoQ, Gross Margin is ...
Novocure (Nasdaq:NVCR) announced that the FDA granted approval for its Optune Pax treatment for advanced pancreatic cancer.
Okta targets 'shadow AI' with new Identity Security Posture Management agent discovery features - SiliconANGLE ...
Optune Pax concomitant with gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancerPhase 3 PANOVA-3 trial showed a ...
This week, a CISA warning, Nest footage in Nancy Guthrie case, Signal phishing. Spanish hacker, Russian asylum. Spanish ...
13h
U.S. FDA Approves Novocure's Optune Pax(R) for the Treatment of Locally Advanced Pancreatic Cancer
Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved Optune Pax (R) for the treatment of adult patients with locally advanced pancreatic cancer concomitant ...
New endpoint-level controls help legal and regulated organizations block confidential data before it reaches AI tools ...
TAIPEI (Taiwan News) — Cyberattacks on government agencies have been increasing, with 637 cybersecurity incidents recorded in ...
ASUS has launched the ROG Strix OLED XG34WCDMTG, a 34-inch ultrawide gaming monitor that blends a high-refresh QD-OLED panel ...
NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announced that top-line data results from its Phase 2a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results